Baseline Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Systemic Immune-Inflammation Index Predict Second-Month Sputum Conversion and Treatment Outcomes in Drug-Resistant Tuberculosis: A Retrospective Cohort Study

Nurhidayah Asjuh; Dyara Aqeela  Fathin

doi:10.58344/ihj.v5i3.948

Authors

Nurhidayah Asjuh Universitas Negeri Makassar
Dyara Aqeela Fathin Universitas Negeri Makassar

DOI:

https://doi.org/10.58344/ihj.v5i3.948

Keywords:

drug-resistant tuberculosis, neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, systemic immune-inflammation index, prognosis, sputum conversion

Abstract

Drug-resistant tuberculosis (DR-TB) remains a major public health challenge, highlighting the need for accessible prognostic biomarkers. This study evaluated the associations of baseline neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and systemic immune-inflammation index (SII) with second-month sputum conversion and treatment outcomes. A retrospective cohort study included 36 adults who initiated DR-TB treatment at Nene Mallomo Hospital, Indonesia, between January 2023 and June 2026. Baseline inflammatory biomarkers were calculated from pretreatment complete blood count results. Statistical analyses included the Mann–Whitney U test, receiver operating characteristic (ROC) curve analysis, and logistic regression. Sputum conversion was evaluated in 31 patients, while the mortality analysis included 24 patients. Baseline NLR was significantly higher among patients with delayed or absent sputum conversion than among those who achieved early conversion (p = 0.048), whereas differences in MLR and SII were not statistically significant. All three biomarkers were significantly elevated among patients who died compared with those who survived. NLR demonstrated the highest observed discriminatory ability for mortality (area under the curve [AUC] = 0.836), followed by MLR (AUC = 0.813) and SII (AUC = 0.766). These findings suggest that elevated systemic inflammatory markers were associated with unfavorable treatment outcomes. However, the small sample size and wide confidence intervals limited the precision and generalizability of the results. Baseline NLR may serve as a potential marker for early risk stratification, although its independent prognostic value remains unconfirmed. Larger prospective multicenter studies are warranted to validate these findings, establish clinically relevant cutoff values, and assess the predictive performance of these biomarkers across diverse DR-TB populations

References

Wang, J., Yuan, B., Fang, Y., Zhao, C., Liu, J., & Xiong, K. (2025). Post-tuberculosis morbidities and their associated mortality: moving from challenges to solutions. European Respiratory Review, 34(178), 250148.

Adane, T., Melku, M., Ayalew, G., Bewket, G., Aynalem, M., & Getawa, S. (2022). Accuracy of monocyte to lymphocyte ratio for tuberculosis diagnosis and its role in monitoring anti-tuberculosis treatment: Systematic review and meta-analysis. Medicine, 101(44), Article e31539. https://doi.org/10.1097/MD.0000000000031539

Alwi, I., Setiati, S., Syam, A. F., Sudoyo, A. W., Simadibrata, M., & Nasution, S. A. (Eds.). (2024). Buku ajar ilmu penyakit dalam (Ed. ke-7, Jilid II). Interna Publishing.

Bastard, M., Sanchez-Padilla, E., Hayrapetyan, A., Kimenye, K., Khurkhumal, S., Dlamini, T., Fadul Perez, S., Telnov, A., Hewison, C., Varaine, F., & Bonnet, M. (2019). What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis? The International Journal of Tuberculosis and Lung Disease, 23(10), 1060–1067. https://doi.org/10.5588/ijtld.18.0649

Centers for Disease Control and Prevention. (2024). 2021 state and city TB report: Sputum culture conversion. Centers for Disease Control and Prevention.

Chen, J., Wang, D., Deng, B., Wang, C., Tang, S., Chen, L., & An, Q. (2026). Neutrophil-to-lymphocyte ratios as easy-to-use biomarkers for the diagnosis of active tuberculosis in children and adolescents. Frontiers in Cellular and Infection Microbiology, 16, Article 1743922. https://doi.org/10.3389/fcimb.2026.1743922

Ferisa, N. P., Dalimunthe, W., Pratita, W., Harahap, J., Lubis, M., & Meirina, F. (2026). NLR (neutrophil-to-lymphocyte ratio), MLR (monocyte-to-lymphocyte ratio) and NMLR (neutrophil-monocyte-to-lymphocyte ratio) as biomarkers for establishing the diagnosis of tuberculosis in children. Indonesian Journal of Global Health Research, 8(1), 957–962. https://doi.org/10.37287/ijghr.v8i1.476

Fritschi, N., Vaezipour, N., Buettcher, M., Portevin, D., Naranbhai, V., & Ritz, N. (2023). Ratios from full blood count as markers for TB diagnosis, treatment, prognosis: A systematic review. The International Journal of Tuberculosis and Lung Disease, 27(11), 822–832. https://doi.org/10.5588/ijtld.22.0598

Greer, J. P., Arber, D. A., Glader, B., List, A. F., Means, R. T., Jr., Paraskevas, F., & Rodgers, G. M. (Eds.). (2014). Wintrobe’s clinical hematology (13th ed.). Wolters Kluwer/Lippincott Williams & Wilkins.

Han, Y., Kim, S. J., Lee, S. H., Sim, Y. S., Ryu, Y. J., Chang, J. H., Shim, S. S., Kim, Y., & Lee, J. H. (2018). High blood neutrophil-lymphocyte ratio associated with poor outcomes in miliary tuberculosis. Journal of Thoracic Disease, 10(1), 339–346. https://doi.org/10.21037/jtd.2017.12.65

Ji, Y., Xie, Q., Wei, W., Huang, Z., Liu, X., Ye, Q., Liu, Y., Lu, X., Lu, Y., Hou, R., Zhang, Q., Xu, Y., Yuan, J., Lu, S., & Yang, C. (2025). Association between blood inflammatory status and the survival of tuberculosis: A five-year cohort study. Frontiers in Immunology, 16, Article 1556857. https://doi.org/10.3389/fimmu.2025.1556857

Kementerian Kesehatan Republik Indonesia. (2023a). Buku pegangan pengendalian tuberkulosis resistan obat dengan paduan BPaLM. Direktorat Jenderal Pencegahan dan Pengendalian Penyakit, Kementerian Kesehatan Republik Indonesia.

Kementerian Kesehatan Republik Indonesia. (2023b). Petunjuk teknis pengobatan tuberkulosis monoresisten INH di Indonesia. Direktorat Jenderal Pencegahan dan Pengendalian Penyakit, Kementerian Kesehatan Republik Indonesia.

Kementerian Kesehatan Republik Indonesia. (2025). Petunjuk teknis penatalaksanaan tuberkulosis resistan obat. Kementerian Kesehatan Republik Indonesia.

Kissling, M., Fritschi, N., Baumann, P., Buettcher, M., Bonhoeffer, J., Naranbhai, V., & Ritz, N. (2023). Monocyte, lymphocyte and neutrophil ratios – Easy-to-use biomarkers for the diagnosis of pediatric tuberculosis. The Pediatric Infectious Disease Journal, 42(6), 520–527.

Koeswaya, M. D., Marliana, N., Abror, Y. K., & Kurniati, I. (2026). Correlation between neutrophil-to-lymphocyte ratio and molecular test Ct category in patients with drug-resistant tuberculosis. Jurnal Riset Kesehatan Poltekkes Depkes Bandung, 18(1), 433–440. https://doi.org/10.34011/juriskesbdg.v18i1.3284

Liu, Y., Li, M., Ding, Y., Gao, Y., Li, T., Wang, X., & Zheng, M. (2025). Clinical utility of monocyte-to-lymphocyte ratio and prognostic nutritional index in diagnosing smear-negative pulmonary tuberculosis with negative IGRA results. Infection and Drug Resistance, 18, 5731–5743. https://doi.org/10.2147/IDR.S554475

Nurfiyana, W., & Amien, A. Z. (2026). Analysis of the relationship between neutrophil-lymphocyte ratio (NLR) values and body mass index in tuberculosis patients. Jurnal Kesehatan, 17(1), 52–58. https://doi.org/10.26630/jk.v17i1.5529

Omair, M., Baig, M. S., Farooqui, W. A., Kousar, S., Noori, M. Y., Zeehan, N., Khan, A., Isa, S., Kamran, D. S., Bari, M. F., & Mehmood, M. (2024). Relationship of neutrophil lymphocyte ratio, monocyte lymphocyte ratio and neutrophil monocyte ratio with treatment response in pulmonary tuberculosis patients during intensive phase treatment. BMC Infectious Diseases, 24, Article 615. https://doi.org/10.1186/s12879-024-09454-2

Regina, P. M., Silaen, J. C., & Sembiring, S. (2024). Neutrophil-lymphocyte ratio and nutritional status as parameters of sputum conversion in MDR-TB before & after 3 months of anti-TB treatment. Jurnal Respirasi, 10, 137–142.

Sormin, D. E., Siagian, P., Sinaga, B. Y. M., & Eyanoer, P. C. (2018). Neutrophyl lymphocyte ratio pada pasien tuberkulosis paru dan tuberkulosis resisten obat. Jurnal Respirologi Indonesia, 38(3), 177–180.

Suryana, K., Dharmesti, N. W. W., & Rai, I. B. N. (2022). High pretreatment level of neutrophil to lymphocyte ratio, monocyte to lymphocyte ratio and other factors associated with delayed sputum conversion in patients with pulmonary tuberculosis. Infection and Drug Resistance, 15, 5455–5462. https://doi.org/10.2147/IDR.S380166

Wang, W., Wang, L. F., Liu, Y. Y., Yang, F., Zhu, L., & Zhang, X. H. (2019). Value of the ratio of monocytes to lymphocytes for monitoring tuberculosis therapy. Canadian Journal of Infectious Diseases and Medical Microbiology, 2019, Article 3270393. https://doi.org/10.1155/2019/3270393

World Health Organization. (2025). Global tuberculosis report 2025. World Health Organization.

Yaja, H., Kashyap, B., & Kotru, M. (2026). Utility of hematological indices in predicting the sputum conversion at the end of the intensive phase of treatment for patients with pulmonary TB. Annals of Pathology and Laboratory Medicine, 13(3), A153–A162. https://doi.org/10.21276/apalm.3789

Yin, Y., Kuai, S., Liu, J., Zhang, Y., Shan, Z., Gu, L., Huang, Q., Pei, H., & Wang, J. (2017). Pretreatment neutrophil-to-lymphocyte ratio in peripheral blood was associated with pulmonary tuberculosis retreatment. Archives of Medical Science, 13(2), 404–411. https://doi.org/10.5114/aoms.2016.60822

Yu, Q., Luo, H., Hu, S., Sun, D., Nie, Q., & Yan, J. (2023). The survival analysis of rifampicin/multidrug-resistant tuberculosis patients based on the levels of inflammatory biomarkers: A retrospective cohort study. Frontiers in Cellular and Infection Microbiology, 13, Article 1118424. https://doi.org/10.3389/fcimb.2023.1118424